How should a patient with a 5 mm distal ureteral stone presenting with pain be treated?

Treatment of 5 mm Distal Ureteral Stone with Pain

For a patient with a 5 mm distal ureteral stone presenting with pain, offer medical expulsive therapy (MET) with an alpha-adrenergic blocker (such as tamsulosin) for approximately 30 days as first-line treatment, with ureteroscopy as an alternative for patients desiring definitive immediate treatment. 1

Initial Management Algorithm

Pain Control (Immediate Priority)

• Provide aggressive pain management immediately—this is mandatory in acute renal colic 2, 3
• Use NSAIDs (diclofenac sodium) as first-line analgesics
• Add opioids if NSAIDs are insufficient

Definitive Treatment Decision

Option 1: Medical Expulsive Therapy (MET) - Preferred Initial Approach

• Strong recommendation for alpha-adrenergic blockers (tamsulosin, alfuzosin, doxazosin, terazosin, or silodosin) for ≤10 mm distal ureteral stones 1
• Duration: approximately 30 days
• Expected outcomes for 5 mm distal stones:
  • Spontaneous passage rate: 89% 2
  • Mean expulsion time: approximately 15 days 4
• MET benefits include:
  • Increased stone passage rates
  • Reduced pain episodes
  • Fewer unplanned healthcare encounters
  • Reduced need for surgical intervention 1

Option 2: Ureteroscopy - For Immediate Definitive Treatment

• Stone-free rate: 95.6% 4
• Mean treatment time: approximately 2 days 4
• Can be performed with conscious sedation safely 5
• Consider as first-line if:
  • Patient preference for immediate resolution
  • Refractory pain despite adequate analgesia
  • Signs of infection
  • Declining renal function
  • Patient unable to tolerate observation period

Key Clinical Considerations

When to Abandon Conservative Management

Stop MET immediately if any of the following develop:

• Infection/fever
• Refractory pain despite adequate analgesia
• Decline in renal function 2

Stone Size Context

At exactly 5 mm, this stone sits at a critical threshold:

• Stones <5 mm: 75% spontaneous passage rate 2
• Stones ≥5 mm: 62% spontaneous passage rate 2
• Distal location significantly improves prognosis (89% passage for <5 mm distal stones) 2

Alternative Surgical Options

If MET fails or is contraindicated:

• Ureteroscopy remains the primary surgical option for distal stones ≤10 mm 1, 4
• ESWL is less commonly recommended for distal ureteral stones in current guidelines, though historically used for stones >5 mm with 80% success rates 6

Common Pitfalls to Avoid

1. Don't delay pain control while deciding on definitive management—pain relief is the immediate priority
2. Don't continue MET beyond 30 days without reassessment
3. Don't ignore signs of infection—this mandates immediate intervention regardless of stone size
4. Don't assume all 5 mm stones will pass—counsel patients that approximately 11% may still require intervention even in the distal ureter

Evidence Quality Note

The recommendation for MET is based on Grade A evidence from a meta-analysis of >8,000 patients 1, representing the highest quality evidence available. The 2026 AUA guideline provides the most recent and authoritative guidance, superseding older treatment paradigms that favored immediate ureteroscopy for all 5 mm stones 6, 4.